UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BMTC
2251
DELISTED
Bryn Mawr Bank Corp
BMTC
| $329K | ﹤0.01% |
10,900
+300
| +3% | +$9.06K |
|
|
AUQ
2252
DELISTED
AURICO GOLD INC COM
AUQ
| $329K | ﹤0.01% |
115,107
+20,417
| +22% | +$67.2K |
|
2253
Exelixis
EXEL
$14.1B
| $328K | ﹤0.01% |
87,194
+3,400
| +4% | +$11.1K |
|
|
XXIA
2254
DELISTED
Ixia
XXIA
| $328K | ﹤0.01% |
26,398
+2,100
| +9% | +$26.2K |
|
|
AMTG
2255
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $328K | ﹤0.01% |
22,299
+5,000
| +29% | +$79.1K |
|
|
IMS
2256
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $328K | ﹤0.01% |
+10,715
| New | +$311K |
|
2257
Primoris Services
PRIM
$4.67B
| $327K | ﹤0.01% |
16,499
+1,500
| +10% | +$28.6K |
|
|
WWE
2258
DELISTED
World Wrestling Entertainment
WWE
| $327K | ﹤0.01% |
19,800
+700
| +4% | +$10.2K |
|
|
VCRA
2259
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $326K | ﹤0.01% |
28,499
+1,500
| +6% | +$16.6K |
|
2260
AngioDynamics
ANGO
$624M
| $325K | ﹤0.01% |
19,829
+3,700
| +23% | +$61.4K |
|
2261
Central Pacific Financial
CPF
$1.03B
| $325K | ﹤0.01% |
13,698
+3,200
| +30% | +$74.6K |
|
2262
Harmony Gold Mining
HMY
$11.4B
| $325K | ﹤0.01% |
242,453
| – | – |
|
2263
iShares Russell Mid-Cap Growth ETF
IWP
$20.5B
| $325K | ﹤0.01% |
6,704
| – | – |
|
|
HA
2264
DELISTED
Hawaiian Holdings, Inc.
HA
| $325K | ﹤0.01% |
13,697
+1,600
| +13% | +$37.4K |
|
|
CGI
2265
DELISTED
Celadon Group Inc
CGI
| $325K | ﹤0.01% |
15,699
+1,100
| +8% | +$27.1K |
|
|
NEWP
2266
DELISTED
NEWPORT CORP
NEWP
| $324K | ﹤0.01% |
17,099
+500
| +3% | +$9.69K |
|
2267
M/I Homes
MHO
$3.83B
| $323K | ﹤0.01% |
13,099
+400
| +3% | +$9.52K |
|
2268
Supernus Pharmaceuticals
SUPN
$2.68B
| $323K | ﹤0.01% |
+19,000
| New | +$270K |
|
|
TGA
2269
DELISTED
Transglobe Energy Corp
TGA
| $322K | ﹤0.01% |
80,797
+2,200
| +3% | +$9.1K |
|
|
PRFT
2270
DELISTED
Perficient Inc
PRFT
| $321K | ﹤0.01% |
16,700
+500
| +3% | +$9.97K |
|
2271
Cass Information Systems
CASS
$730M
| $320K | ﹤0.01% |
7,524
| – | – |
|
2272
Omeros
OMER
$922M
| $320K | ﹤0.01% |
17,800
+4,500
| +34% | +$97.1K |
|
|
BFX
2273
DELISTED
BowFlex Inc.
BFX
| $320K | ﹤0.01% |
+14,900
| New | +$296K |
|
2274
First Merchants
FRME
$2.72B
| $319K | ﹤0.01% |
12,900
+3,800
| +42% | +$89.6K |
|
2275
Koppers
KOP
$989M
| $319K | ﹤0.01% |
12,900
+2,600
| +25% | +$62.9K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.